New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2013
09:24 EDTEPOC, ATHN, NSM, BAC, VVUS, ILMN, SQNM, RHHBYOn The Fly: Pre-market Movers
HIGHER: Epocrates (EPOC), up 22.6% after agreeing to be acquired by athenahealth (ATHN) for $11.75 per share, in cash... VIVUS (VVUS), up 9.6% after reporting strong growth in Qsymia prescriptions shipped to patients in December... Nationstar Mortgage Holdings (NSM), up 18.6% after confirming deal to acquire about $215B in mortgage servicing assets from Bank of America (BAC). Shares of BofA also up 0.7%... LOWER: Illumina (ILMN), down 9% after acquiring Verinata Health for $350M, Roche's (RHHBY) chairman reportedly says his company no longer looking to acquire Illumina... Sequenom's (SQNM), down 6.5% after reporting preliminary 2012 revenue, which William Blair says may be overshadowed by Illumina's acquisition of Verinata.
News For EPOC;ATHN;NSM;BAC;VVUS;ILMN;SQNM;RHHBY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
October 20, 2014
07:04 EDTRHHBYRoche approval would be positive for TESARO, says Jefferies
Subscribe for More Information
06:38 EDTATHNathenahealth price target lowered to $115 from $140 at RBC Capital
Subscribe for More Information
October 17, 2014
16:55 EDTBACStocks end volatile week lower amid oil price plunge
Subscribe for More Information
09:17 EDTATHNOn The Fly: Pre-market Movers
Subscribe for More Information
08:05 EDTATHNathenahealth reports Q3 adjusted EPS 27c, consensus 27c
athenahealth last night reported Q3 revenue $190.4M, consensus $190.4M. The company reported it grew net new active physicians on athenaCollector, which had 3,420 physicians added, athenaClinicals, which had 2,786 physicians added, and athenaCommunicator, which had 3,846 physicians added, for the three months ended September 30.
October 16, 2014
18:36 EDTATHNOn The Fly: After Hours Movers
Subscribe for More Information
16:07 EDTATHNathenahealth now sees FY14 EPS near high end of range
athenahealth said, "We are not making any changes to the fiscal year 2014 guidance...However, based on our year-to-date performance and current expectations for Q4 2014, we are providing additional insight into our fiscal year 2014 guidance as follows: "We expect GAAP Total Revenue to be at or above the mid-point of the $725M-$755M guidance range. We expect Non-GAAP Adjusted Gross Margin to be close to the mid-point of the 62.5% to 63.5% guidance range. We expect Non-GAAP Adjusted Net Income per Diluted share to be close to the high end of the 98c-$1.10 guidance range."
16:05 EDTATHNathenahealth sees FY14 adjusted EPS 98c-$1.10, consensus $1.09
Subscribe for More Information
14:47 EDTRHHBYRoche in pact with Pharmacyclics to evaluate Imbruvica, Gazyva combo
Subscribe for More Information
14:09 EDTBACApple confirms October 20 start date for Apple Pay
Apple (AAPL) announced that customers can start making payments on Monday, October 20, when Apple Pay becomes available in the U.S. Users of the iPad Air 2 and iPad mini 3 will be able to use Touch ID on their devices for Apple Pay within apps. The new service will be enabled by a free software update to iOS 8. Apple Pay supports credit and debit cards from the three major payment networks: American Express (AXP), MasterCard (MA) and Visa (V). In addition to American Express, Bank of America (BAC), Capital One Bank (COF), Chase (JPM), Citi (C), Wells Fargo (WFC) and others, who announced support in September, more than 500 new banks from across the country have signed on to Apple Pay, the company said.
13:13 EDTRHHBYRoche considers submitting Ebola test for emergency use approval, WSJ says
Subscribe for More Information
10:01 EDTILMN, BACOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:35 EDTRHHBYDiplomat announces contract to distribute Esbriet
Subscribe for More Information
08:27 EDTBACBank of America weakness overdone, buy shares, says Morgan Stanley
Subscribe for More Information
08:23 EDTBACBofA CEO steps point to extended stay in post, Reuters reports
Bank of America Chairman and CEO Brian Moynihan has taken more control over the bank's retail business, has shifted executives into new positions and his sway with directors has increased since he recently became chairman, all of which signal that he plans to remain at the bank for "a minimum of five years," according to Reuters, citing sources familiar with the matter. Reference Link
07:44 EDTBACBank of America quarterly results trumped by market sell-off, says UBS
UBS believes Bank of America posted better than expected earnings with core expenses declining, but that the results were overshadowed by the market sell-off. The firm saw improved expense management and believes the company's changes to its portfolio will eventually be impacted by short term interest rates. UBS reiterates its Buy rating and $20 price target on Bank of America.
05:58 EDTRHHBYRoche sees FY14 core EPS targeted to grow ahead of sales
Subscribe for More Information
05:57 EDTBACBank of America upgraded to Outperform from Market Perform at FBR Capital
FBR Capital upgraded Bank of America to Outperform with a $20 price target citing book value growth following the company's Q3 results. Shares closed yesterday down 28c to $15.48.
05:56 EDTRHHBYRoche reports 9 month revenue CHF34.76B vs. CHF34.87B last year
Roche CEO Severin Schwan said: “Demand for our products is strong in both divisions and we are well on track to reach our full-year targets. We have had positive news from our product pipeline, including study results for Perjeta in breast cancer and a new combination therapy with Zelboraf in melanoma. The InterMune acquisition has also strengthened our portfolio with a new medicine, Esbriet for idiopathic pulmonary fibrosis, which has now been approved by the FDA. In Diagnostics, growth continues to be driven by the immunodiagnostics business and we have strengthened our molecular diagnostics portfolio with a new generation of testing systems.”
05:33 EDTILMNIllumina upgraded to Overweight from Neutral at Piper Jaffray
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use